Intravesical Oxybutynin: A Local Anesthetic Effect on Bladder C Afferents
- 1 May 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (5) , 1892-1895
- https://doi.org/10.1097/01.ju.0000049903.60057.4b
Abstract
Purpose: Intravesical oxybutynin is used to control bladder overactivity in patients who are refractory to or cannot tolerate oxybutynin given orally. Although it is clinically effective, the mode of action of intravesical oxybutynin remains unclear. We tested the influence of intravesical oxybutynin on single fiber pelvic nerve afferents from the rat bladder. Materials and Methods: A total of 15 single afferent bladder units were identified. Based on conduction velocity they were grouped as Aδ or C fibers. The effect of repeat bladder filling was studied on the mechanosensitive properties of these units. Oxybutynin was than instilled and left in the bladder for 15 minutes. Unitary afferent activity was again analyzed 15, 60 and 90 minutes after the drug was removed. Results: Repeat bladder filling did not change nerve activity in Aδ or C fibers. At 15 minutes after oxybutynin was washed out of the bladder C fiber afferents responded significantly less to intravesical pressure and volume compared with control filling. At 60 minutes C fibers partly regained mechanosensivity. After 90 minutes sensitivity still increased without achieving the response level before oxybutynin. No significant changes were noted in Aδ fibers during repeat bladder filling or after oxybutynin instillation. Conclusions: In this study we showed that intravesical oxybutynin has a direct anesthetic effect within the bladder wall. It temporarily desensitizes C fiber afferents, which could explain its clinical benefits in decreasing symptoms of bladder overactivity. No measurable effect was found on Aδ fibers.Keywords
This publication has 13 references indexed in Scilit:
- Bladder afferents and their role in the overactive bladderUrology, 2002
- INTRAVESICAL OXYBUTYNIN: MODE OF ACTION ASSESSED BY PASSIVE DIFFUSION AND ELECTROMOTIVE ADMINISTRATION WITH PHARMACOKINETICS OF OXYBUTYNIN AND N-DESETHYL OXYBUTYNINJournal of Urology, 2001
- Intravesical oxybutynin for treating incontinence resulting from an overactive detrusorBJU International, 2001
- INTRAVESICAL OXYBUTYNIN FOR NEUROGENIC BLADDER DYSFUNCTION: LESS SYSTEMIC SIDE EFFECTS DUE TO REDUCED FIRST PASS METABOLISMJournal of Urology, 1998
- INTRAVESICAL APPLICATION OF A STABLE OXYBUTYNIN SOLUTION IMPROVES THERAPEUTIC COMPLIANCE AND ACCEPTANCE IN CHILDREN WITH NEUROGENIC BLADDER DYSFUNCTIONJournal of Urology, 1998
- Distribution of afferent axons in the bladder of ratsJournal of Neurocytology, 1998
- Intravesical Application of Oxybutynine: Mode of Action in Controlling Detrusor Hyperref lexiaEuropean Urology, 1995
- The Pharmacokinetics of Intravesical and Oral Oxybutynin ChlorideJournal of Urology, 1992
- In vitro Intravesical Instillation of Anticholinergic, Antispasmodic and Calcium Blocking Agents to Decrease Bladder ContractilityUrologia Internationalis, 1991
- Conduction velocity distribution of afferent fibers innervating the rat urinary bladderBrain Research, 1990